Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 5/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.39 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.39 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12421900 | 0.96 | HPGD (0.50) | HPGDTSHRHTTSMN1; SMN2PLK1 | |
| SCHEMBL14675648 | 0.84 | RAB9A (0.51) | HPGDTSHRSMN1; SMN2HRH3KCNH2 | |
| SCHEMBL12414355 | 0.83 | CA1 (0.39) | HPGDHTTSMN1; SMN2PLK1MMP13 | |
| SCHEMBL277428 | 0.82 | SMN1; SMN2 (0.41) | HPGDSMN1; SMN2GLANPSR1 | |
| SCHEMBL13649518 | 0.81 | KMT2A (0.47) | TSHRHTTSMN1; SMN2HDAC8HDAC6 | |
| SCHEMBL2607958 | 0.80 | GLA (0.46) | HPGDTSHRSMN1; SMN2GLAHSD17B10 | |
| SCHEMBL14755842 | 0.80 | SRD5A1 (0.47) | HPGDSMN1; SMN2GLAKDM4EALDH1A1 | |
| SCHEMBL12410677 | 0.79 | HPGD (0.48) | HPGDHTTSMN1; SMN2ALDH1A1 | |
| SCHEMBL17462699 | 0.78 | MMP13 (0.49) | HPGDHTTSMN1; SMN2MMP13GLA | |
| SCHEMBL7109646 | 0.77 | PARP10 (0.46) | GLAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2739608-B1 | INSULIN SECRETION PROMOTING AGENTS | VAL-CHUM LTD PARTNERSHIP (CA) | 2017-09-06 | — | — | EP | disclosed |
| EP-2739608-B1 | INSULIN SECRETION PROMOTING AGENTS | VAL-CHUM LTD PARTNERSHIP (CA) | 2017-09-06 | — | — | EP | disclosed |
| US-9518016-B2 | Insulin secretion promoting agents | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2016-12-13 | — | — | US | disclosed |
| US-9518016-B2 | Insulin secretion promoting agents | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2016-12-13 | — | — | US | disclosed |
| US-9518016-B2 | Insulin secretion promoting agents | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2016-12-13 | — | — | US | disclosed |
| US-20160264527-A1 | INSULIN SECRETION PROMOTING AGENTS | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL (CA) | 2016-09-15 | — | — | US | disclosed |
| US-20160264527-A1 | INSULIN SECRETION PROMOTING AGENTS | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL (CA) | 2016-09-15 | — | — | US | disclosed |
| US-20160264527-A1 | INSULIN SECRETION PROMOTING AGENTS | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL (CA) | 2016-09-15 | — | — | US | disclosed |
| US-9371285-B2 | Insulin secretion promoting agents | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2016-06-21 | — | — | US | disclosed |
| US-9371285-B2 | Insulin secretion promoting agents | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2016-06-21 | — | — | US | disclosed |
| US-9371285-B2 | Insulin secretion promoting agents | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2016-06-21 | — | — | US | disclosed |
| WO-2015127559-A1 | ABHD6 ANTAGONISTS FOR PROMOTING BROWNING OF WHITE ADIPOSE TISSUE AND BROWN ADIPOSE TISSUE FUNCTIONALITY | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2015-09-03 | — | — | WO | disclosed |
| WO-2015127559-A1 | ABHD6 ANTAGONISTS FOR PROMOTING BROWNING OF WHITE ADIPOSE TISSUE AND BROWN ADIPOSE TISSUE FUNCTIONALITY | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2015-09-03 | — | — | WO | disclosed |
| US-20140163077-A1 | INSULIN SECRETION PROMOTING AGENTS | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2014-06-12 | — | — | US | disclosed |
| US-20140163077-A1 | INSULIN SECRETION PROMOTING AGENTS | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2014-06-12 | — | — | US | disclosed |
| US-20140163077-A1 | INSULIN SECRETION PROMOTING AGENTS | VAL-CHUM, LIMITED PARTNERSHIP (CA) | 2014-06-12 | — | — | US | disclosed |
| EP-2739608-A1 | INSULIN SECRETION PROMOTING AGENTS | Centre Hospitalier de l'Université de Montréal (CA) | 2014-06-11 | — | — | EP | disclosed |
| WO-2013016807-A1 | INSULIN SECRETION PROMOTING AGENTS | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL (CA) | 2013-02-07 | — | — | WO | disclosed |
| WO-2013016807-A1 | INSULIN SECRETION PROMOTING AGENTS | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL (CA) | 2013-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160264527-A1 | INSULIN SECRETION PROMOTING AGENTS | IAPP, GPR119, PNLIP | HPGD 1875/4885TSHR 1100/4885HTT 2598/4885 |
| US-20140163077-A1 | INSULIN SECRETION PROMOTING AGENTS | IAPP, GPR119, PNLIP | HPGD 1875/4885TSHR 1100/4885HTT 2598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.